Catalyst Pharmaceuticals Inc. (CPRX)

Catalyst Pharmaceuticals Inc. (CPRX $25.27)
- $25.27 P/E (TTM): 14.98X Cap: $3.12B
- View CPRX Profile
- View Questions on CPRX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $451.38)
- $451.38 P/E (TTM): 58.74X Cap: $161.56B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $440.45)
- $440.45 P/E (TTM): 29.03X Cap: $113.68B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $211.62)
- $211.62 P/E (TTM): 89.66X Cap: $375.68B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $238.82)
- $238.82 P/E (TTM): 21.88X Cap: $581.22B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $940.80)
- $940.80 P/E (TTM): 41.54X Cap: $902.48B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $121.69)
- $121.69 P/E (TTM): 16.92X Cap: $303.17B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $170.47)
- $170.47 P/E (TTM): 20.63X Cap: $8.30B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $572.08)
- $572.08 P/E (TTM): 45.25X Cap: $46.49B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $67.26)
- $67.26 P/E (TTM): 25.86X Cap: $7.94B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $96.14)
- $96.14 P/E (TTM): 14.96X Cap: $19.29B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $25.27)
- $25.27 P/E (TTM): 14.98X Cap: $3.12B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $28.92)
- $28.92 P/E (TTM): 372.47X Cap: $237.13B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

AbbVie Inc. (ABBV $211.62)
- $211.62 P/E (TTM): 89.66X Cap: $375.68B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $940.80)
- $940.80 P/E (TTM): 41.54X Cap: $902.48B
- View LLY Profile
- View Questions on LLY
Cipher Pharmaceuticals Inc. (CPH $18.82)
- $18.82 P/E (TTM): 12.63X Cap: $470M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Halozyme Therapeutics Inc. (HALO $67.26)
- $67.26 P/E (TTM): 25.86X Cap: $7.94B
- View HALO Profile
- View Questions on HALO
uniQure N.V. (QURE $15.65)
- $15.65 Cap: $1.08B
- View QURE Profile
- View Questions on QURE
Catalyst Pharmaceuticals Inc. (CPRX $25.27)
- $25.27 P/E (TTM): 14.98X Cap: $3.12B
- View CPRX Profile
- View Questions on CPRX

Q: Hi, could you suggest a couple each of your fav. small, mid and large cap biotech stocks and why you like them.

thanks, M

Read Answer Asked by Mark on October 08, 2025

Catalyst Pharmaceuticals Inc. (CPRX $25.27)
- $25.27 P/E (TTM): 14.98X Cap: $3.12B
- View CPRX Profile
- View Questions on CPRX
Elevance Health Inc. (ELV $318.29)
- $318.29 P/E (TTM): 12.67X Cap: $69.60B
- View ELV Profile
- View Questions on ELV

Q: What's your opinion about these two stocks? Buy/Hold/Sell? Timeframe: 3-5 years. Risk tolerance: moderate.

Read Answer Asked by Paul on September 12, 2025